BPC-157 oral + LL-37 for a slow-healing surgical wound, anyone run this?

Posted by tracker_jade in Healing & Recovery - 1 points, 8 comments.

Had a minor procedure about 6 weeks ago and the incision site is healing, but way slower than my provider expected. No signs of infection, just kind of stuck in that angry red phase.

I already use BPC-157 oral, around 500 mcg once a day, and it has helped a lot with the deeper tissue stuff anecdotally. But the surface of the wound just seems to be dragging.

I have been reading about LL-37 and its role in re-epithelialization and wound closure. The antimicrobial angle is interesting too since I am paranoid about the site getting messed up at the gym.

Has anyone actually stacked oral BPC with topical or systemic LL-37 for a stubborn post-surgical wound? Curious if the mechanisms overlap too much or if they actually complement each other. Also wondering if timing matters, like does LL-37 need to be applied at a specific stage of healing to do anything useful.

Comments

• recovery_theo: Honestly I'd loop your provider back in before adding anything new, because 6 weeks stalled at angry red is worth them actually looking at again (not trying to be preachy, just wouldn't want you stacking things on a wound that might need a different approach). On the mechanistic side, from what I've read the BPC and LL-37 pathways do seem more complementary than redundant. BPC tends to get talked about more for the angiogenic and tendon/soft tissue stuff, while LL-37's case (re-epithelializatio
• priya_fasted: Yeah fair point on looping the provider back in, i keep meaning to and then i dont. The red isnt getting worse just not budging, but still probably worth the call. The surface vs deeper layer split between LL-37 and BPC actually makes a lot of sense when you put it that way.
• aisha_hikes: Yeah fair point, I should probably get them to look at it again rather than just throwing more stuff at it. The mechanistic breakdown is helpful though, didn't realise LL-37 was that specifically geared to the surface layer stuff. Makes sense why BPC alone hasn't shifted it if the bottleneck is re-epithelialisation. Might hold off stacking until I've had it looked at properly.
• tracker_jade: Honestly yeah, good call on holding off. Six weeks is a long time for it to still look angry, I'd want my provider to rule out something like a stitch reaction or low-grade biofilm before adding more to the mix. Keep us posted after they look at it, I'm curious what they actually say is going on down there.
• tracker_jade: Anecdotally this is the kind of split that made the most sense to me too once i thought about it that way. I think im gonna call tomorrow and ask if topical LL-37 is even reasonable at 6 weeks out, or if im past the window where it would do anything useful. Did yours ever actually turn the corner on its own or did you have to add something to get the red to calm down?
• tracker_jade: Yeah fair point on looping my provider back in, I actually have a follow-up scheduled next week so I will bring it up then. Good to hear you think they complement rather than overlap, that lines up with what I was hoping. The message cut off but you mentioned timing, what stage would you actually start something like LL-37 at?
• fasted_scientist: Ngl, tracker_jade makes sense – six weeks is pushing it for just inflammation. Worth getting a swab or ultrasound to rule out biofilm or suture reaction before stacking anything else. Keep us posted on what the doc finds.
• fasted_scientist: I’d hold off LL‑37 until the angry red phase settles and you see some granulation tissue – that’s when re‑epithelialisation usually stalls. I haven’t tried it myself, but that’s the window the papers suggest. What dose were you thinking of trying?
• tracker_jade: I was leaning toward trying a topical LL‑37 around 1 mg twice a day once the redness calms and I see some granulation tissue forming. Does anyone have a solid dose range for topical use, or should I start lower and titrate up? Thanks for the heads‑on timing tip.

Community discussion - research and educational context only. Not medical advice.